← Back to all earnings calls

Sutro Biopharma, Inc. Q1 FY2025 Earnings Call

Sutro Biopharma, Inc. (STRO)

Earnings Call FY2025 Q1 Call date: 2025-05-08 Concluded

Share

Quarter scorecard

Revenue

$17.40M

+33.8% YoY

Diluted EPS

$-9.08

Net income

-$75.97M

Documents & deck